‘Little bit early’ to say Moderna is the ‘savior’ in the COVID-19 vaccine race: Analyst

Yahoo Finance’s Akiko Fujita and Jared Holz, Healthcare Equity Strategy at Jefferies, discuss competition for a COVID-19 vaccine as AstraZeneca strikes a deal with the U.S. for an antibody treatment. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.